Pediatric nephrology (Berlin, Germany)
Pediatric nephrology (Berlin, Germany)
Audio Summaries
Every issue of Pediatric nephrology (Berlin, Germany) moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Pediatric nephrology (Berlin, Germany).
Correlation between albumin and protein excretion in first morning, random spot, and 24-h urine specimens in children with glomerular diseases.
Nov 18, 2026
This study asked whether spot urine protein-to-creatinine ratios (PCR) and albumin-to-creatinine ratios (ACR) correlate with 24-hour urine protein and albumin measurements in children with glomerular diseases. In 169 patients aged 3-18 years, first-morning and random spot PCR and ACR correlated strongly with their 24-hour counterparts (r = 0.85-0.95), and ACR thresholds of 1540 and 77 mg/g best corresponded to PCR values of 2 and 0.2 mg/mg. Because agreement varied across the proteinuria range, the authors conclude these measures should not be treated as interchangeable without further validation.
Time-course of platelet count in children with hemolytic uremic syndrome: data from the ItalKid-HUS Network.
Nov 18, 2026
This retrospective study of 148 children with STEC-HUS treated at one center (2010–2025) asks what the typical time course of platelet recovery looks like, so that deviations can flag complications. Aligning each patient to their platelet nadir (median 23,000/μL, reached around day 8 of symptoms), the authors found that all patients reached >150,000/μL by 14 days after nadir. They propose these reference trajectories as a benchmark for identifying atypical HUS, disseminated intravascular coagulation, or heparin-induced thrombocytopenia when platelet recovery lags.
Kidney phenotype and clinical course in children with AMN-related Imerslund-Gräsbeck syndrome: a multicenter cohort.
Nov 17, 2026
This multicenter retrospective study of nine Turkish children with homozygous pathogenic AMN variants asks what kidney phenotype and clinical course accompany Imerslund-Gräsbeck syndrome presenting with proteinuria. The children had persistent subnephrotic-range proteinuria, but kidney function remained generally preserved (final eGFR >90 mL/min/1.73 m² in all, with no progression to advanced CKD, nephrotic syndrome, or dialysis/transplant needs over a median 30-month follow-up). The authors conclude that early genetic diagnosis may help avoid unnecessary kidney biopsy and inappropriate immunosuppression, while noting that RAS inhibitor efficacy could not be determined.
Impact of donor size on short- and long-term outcomes in pediatric kidney transplant recipients: where is the mismatch limit? Analysis of the Scientific Registry of Transplant Recipients database.
Nov 16, 2026
This SRTR-based cohort study of 5,321 pediatric kidney transplant recipients (2010–2020) asked whether donor-to-recipient height mismatch affects outcomes after transplantation. A higher donor-to-recipient height ratio was associated with increased graft loss (HR 1.90), but this risk decreased with recipient age, and no significant differences were found for acute rejection or overall survival. The authors conclude that height matching matters most in young children, while larger adult donor kidneys remain a reasonable option for children with end-stage kidney disease because the benefits of transplantation outweigh the mismatch risk.
Quality improvement in neonatal critical care nephrology and CKRT programs.
Nov 13, 2026
This review examines how quality improvement (QI) methods have advanced neonatal acute kidney injury (AKI) care and continuous kidney replacement therapy (CKRT), a low-volume, high-complexity area where traditional research is often limited. The authors ask how collaborative QI efforts, such as neonatal-specific AKI definitions, surveillance, nephrotoxin stewardship, and registries, can address persistent variability and gaps in CKRT practice, which is still largely extrapolated from adult and older pediatric data. They conclude that interdisciplinary collaboration, shared data infrastructure, and neonatal-specific quality indicators are needed to achieve standardized, equitable kidney care for vulnerable neonates.
Caffeine for prevention of acute kidney injury in neonates with perinatal asphyxia: a randomized placebo-controlled trial.
Nov 13, 2026
This double-blind randomized controlled trial asked whether a single intravenous dose of caffeine citrate (20 mg/kg) given within 2 hours of birth could prevent acute kidney injury in term and late-preterm neonates (≥35 weeks) with perinatal asphyxia. In 78 neonates, AKI occurred in 28.2% of the caffeine group and 35.9% of the normal saline group, a difference that was not statistically significant (p = 0.467), and there were also no significant differences in AKI severity, kidney and cerebral markers, HIE incidence, or neurological scores at discharge. The authors concluded that a single caffeine dose at birth did not reduce AKI or HIE, and they call for further research on dosing, frequency, and use in infants receiving therapeutic hypothermia.
Association of graft survival with tacrolimus metabolism in pediatric and young adult kidney transplant recipients: an international Collaborative Transplant Study analysis.
Nov 11, 2026
This study examined whether tacrolimus metabolism, measured as the one-year concentration-to-dose ratio (CDR) normalized to body weight, predicts death-censored graft loss in 3,768 pediatric and young adult kidney transplant recipients from the Collaborative Transplant Study. A CDR below 0.58 was independently linked to higher graft failure risk in adolescents (aHR 1.74) and young adults (aHR 1.98), but not in children, with the association strongest among young adults with positive baseline PRA. The findings suggest low tacrolimus metabolism identifies adolescents and young adults as a high-risk group warranting age-specific, individualized immunosuppression.
Collaborative decision-making among pediatric nephrology providers: a qualitative study.
Nov 11, 2026
This qualitative study interviewed 17 multidisciplinary pediatric nephrology providers from two U.S. children's hospitals to explore their roles in collaborative decision-making with patients and families, the barriers they face, and how they address them. Providers described guiding families through complex decisions and tailoring discussions to individual factors, but reported difficulty eliciting values due to limited clinic time, relationship-building challenges, and misaligned values, and some described avoiding shared decisions altogether. The authors conclude that providers need more support to engage in collaborative decision-making, elicit values, and navigate conflict.
Post-transplant erythrocytosis (PTE) in pediatric kidney transplantation: a case report and literature review.
Nov 11, 2026
Post-transplant erythrocytosis (PTE) is a known complication in adult kidney transplant recipients linked to thrombotic risk, but its pediatric presentation is poorly characterized. This paper reports a case of PTE in a 5-year-old boy and reviews the pediatric literature on its risk factors (male sex, prolonged dialysis, non-preemptive transplantation, preserved graft function), pathophysiology, and management. The authors aim to raise awareness of PTE in children and highlight that treatment, largely extrapolated from adult data (first-line ACE inhibitors or ARBs, with phlebotomy, theophylline, or immunosuppression adjustments as alternatives), needs further study.
Outcome of children with IgA vasculitis with nephritis treated with oral immunosuppressive treatment in combination with steroids.
Nov 11, 2026
This multicenter retrospective study asked whether adding oral immunosuppressive therapy to corticosteroids improves long-term kidney remission in children with biopsy-proven IgA vasculitis nephritis. Comparing 33 children treated with immunosuppression plus steroids against 33 matched children treated with steroids alone, the authors found similar remission rates (70% vs. 66%, p = 0.79), although immunosuppression produced a faster reduction in proteinuria. Older age and delayed initiation of immunosuppression were associated with lower remission likelihood, but given the small sample, the authors call for prospective studies to define its role and timing.
